Health Information Technology's Impact on Adherence to Lipid Therapy
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerCardiometabolic Consequences of Sitting Time
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerGenerics and Manufacturing: What Prescribers Need to Know
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerGenetic Testing for Familial Hypercholesterolemia
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerResearch Updates in Familial Hypercholesterolemia
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerResearch Updates on Postprandial Dyslipidemia Treatment
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerLipid Biomarker Updates: When to Move Beyond the Standard Profile
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerWhat is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerAdiposity, Obesity, and Dyslipidemia
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerUnderrecognition of Diabetes in Cardiology Practice
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerAn Avocado a Day: Does It Keep Heart Disease Away?
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerThe Impact of Inflammation on HDL Activity
Alan S. Brown, MD, FACC, FAHA, FNLA
PeerLee Philip Shulman, MD, FACOG, FACMG
PeerAdvancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 3
Matt Birnholz, MD
PeerAdvancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 2
Matt Birnholz, MD
Peer